American Journal of Infection Control

During viral respiratory pandemics in the twenty-first century, most health care workers have used lightweight disposable filtering facepiece respirators (FFRs) and should have undergone quantitative fit testing (QNFT) as a part of a dedicated

SARS-CoV-2 infection poses a particularly acute risk to end stage renal disease (ESRD) patients. During the first seven months of the pandemic, it is estimated that excess deaths in this population were 8.7-12.9 per 1000 patients1. In a study of ESRD

During the Coronavirus Disease of 2019 (COVID-19) pandemic, while much of the population was able to limit exposure to non-household members, healthcare personnel (HCP) continued to be at exposure risk. Despite national guidelines and internal

A global pandemic of novel coronavirus, SARS-CoV-2, was declared by the World Health Organization on March 11, 2020. The first reported death from COVID-19 in the United States was an End Stage Renal Disease (ESRD) patient1. Accumulating data show

During the coronavirus disease 2019 (COVID-19) pandemic, there have been recommendations of safe distances from other people (eg, 2 m), including within operating rooms (ORs).1 Distancing is a theme of public conversation,2 including during tracheal

SARS-CoV-2, the virus that causes COVID-19, is primarily spread person-to-person via contact with infected respiratory droplets.1 It is estimated that an individual may be infectious prior to becoming symptomatic.2 Areas with crowded work spaces and